Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02504489
Title Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC (DUBLIN-3)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors BeyondSpring Pharmaceuticals Inc.

lung non-small cell carcinoma



Docetaxel + Plinabulin

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST